Back to Stakeholders
Federal AgenciesGrant-Making Organizations

National Cancer Institute (NCI)

United States
3 Trials

The National Cancer Institute (NCI) is the principal US federal agency for cancer research and training, one of 27 institutes within the National Institutes of Health, with an annual budget exceeding $7 billion. In the psychedelic field, NCI has supported trials exploring psilocybin-assisted therapy for cancer-related demoralization and chronic pain in survivors, as well as ketamine infusion to prevent depression in patients undergoing treatment for pancreatic and head-and-neck cancers.

Quick Facts

Type
Other
HQ
United States
Website
Visit

Collaborated Trials

3
RecruitingII, III

Psilocybin Therapy in Advanced Cancer

Start Date
Compounds
Psilocybin, Placebo
CompletedI

Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain

Start Date
Compounds
Psilocybin
WithdrawnI

Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers

Start Date
Compounds
Ketamine, Placebo